The PATH Malaria Vaccine Initiative (MVI) has been working with partners to assess community perceptions of vaccines and malaria in countries that are hosting malaria vaccine clinical trials. The findings will be used to develop communications strategies and materials and to add to the data and evidence that African policymakers need as they plan for timely decisions on the future role of a malaria vaccine.